- $801.08m
- $669.44m
- $0.21m
Brief: Chimerix To Report First Quarter 2023 Financial Results
Brief: Chimerix Considers Its Exposure To Any Liquidity Concern At SVB As Immaterial
U.S. RESEARCH ROUNDUP-Itron, Marathon Petroleum, Radius Global Infrastructure
U.S. STOCKS ON THE MOVE-Kroger, Utz, Dexcom
Chimerix rises after upbeat 2022 revenue
Chimerix Inc reports results for the quarter ended in December - Earnings Summary
Brief: Chimerix Reports Fourth Quarter Net Income USD -20.96 million
Chimerix Inc expected to post a loss of 24 cents a share - Earnings Preview
Chimerix Inc expected to post a loss of 24 cents a share - Earnings Preview
Refile: BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Starbucks, ASLAN Pharma
U.S. STOCKS ON THE MOVE-Jasper Therapeutics, Blackstone, Mondelez
U.S. STOCKS ON THE MOVE-Horizon Global, Apple, PayPal Holdings
Jefferies sees opportunity in biotech stocks trading below cash level
U.S. STOCKS ON THE MOVE-Johnson Outdoors, agilon health, Phreesia
Chimerix falls as co plans to slash workforce
Brief: Chimerix Announces Successful Launch Of ONC201 Phase 3 Study At Society For Neuro-Oncology Conference And Provides Operational Update
Brief: Chimerix Responds To Rubric Capital Management
Chimerix Inc reports results for the quarter ended in September - Earnings Summary
Brief: Chimerix Reports Third Quarter 2022 Financial Results